Skip to content

Petros Pharmaceuticals, Inc.: 10-Q filed 2021-11-15

What Petros Pharmaceuticals, Inc. reported in its quarterly report filed 2021-11-15 (fiscal Q3 2021): 46 published measures, 125 facts as tagged in accession 0001104659-21-139299.

This filing

Form
10-Q (quarterly report)
Filed
2021-11-15
Fiscal period
fiscal Q3 2021
Accession
0001104659-21-139299 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Petros Pharmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2021-09-3052,035,328USD
At 2020-12-3169,854,014USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2021-09-3034,188,332USD
At 2020-12-3152,384,962USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2021-09-3017,846,996USD
At 2021-06-3019,490,727USD
At 2020-12-3117,469,052USD
At 2020-09-30-7,128,734USD
At 2020-06-30-3,828,371USD
At 2019-12-318,019,219USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2021-09-308,135,184USD
At 2020-12-3117,139,694USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,696,898USD92
2021-01-01 to 2021-09-30-800,734USD273
2020-07-01 to 2020-09-30-3,300,363USD92
2020-01-01 to 2020-09-30-15,147,953USD274

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-3,557,732USD273
2020-01-01 to 2020-09-30-10,782,430USD274

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2020-01-01 to 2020-09-304,633USD274

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,145,169USD92
2021-01-01 to 2021-09-308,678,424USD273
2020-07-01 to 2020-09-303,464,695USD92
2020-01-01 to 2020-09-306,630,180USD274

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-5,446,778USD273
2020-01-01 to 2020-09-309,310,326USD274

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-4,633USD274

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2021-09-30-62,502,878USD
At 2020-12-31-61,702,144USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2021-07-01 to 2021-09-309,826,599shares92
2021-01-01 to 2021-09-309,794,267shares273
2020-07-01 to 2020-09-303,434,551shares92
2020-01-01 to 2020-09-303,434,551shares274

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2021-07-01 to 2021-09-309,826,599shares92
2021-01-01 to 2021-09-309,794,267shares273
2020-07-01 to 2020-09-303,434,551shares92
2020-01-01 to 2020-09-303,434,551shares274

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.17USD/shares92
2021-01-01 to 2021-09-30-0.08USD/shares273
2020-07-01 to 2020-09-30-0.96USD/shares92
2020-01-01 to 2020-09-30-4.41USD/shares274

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-0.17USD/shares92
2021-01-01 to 2021-09-30-0.08USD/shares273
2020-07-01 to 2020-09-30-0.96USD/shares92
2020-01-01 to 2020-09-30-4.41USD/shares274

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2021-07-01 to 2021-09-302,345USD92
2021-01-01 to 2021-09-309,045USD273
2020-07-01 to 2020-09-30-6,143USD92
2020-01-01 to 2020-09-30-49,895USD274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2021-09-3051,952USD
At 2020-12-3164,250USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2021-01-01 to 2021-09-30990,876USD273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-3,596,617USD92
2021-01-01 to 2021-09-30-10,074,816USD273
2020-07-01 to 2020-09-30-2,336,421USD92
2020-01-01 to 2020-09-30-12,964,054USD274

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2021-09-3013,354,324USD
At 2020-12-3125,905,053USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2021-09-3033,500,583USD
At 2020-12-3141,894,042USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2021-09-3026,982,098USD
At 2020-12-3132,160,919USD
At 2019-12-3138,811,137USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2021-09-301,952,421USD
At 2020-12-315,152,969USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2021-07-01 to 2021-09-305,422,628USD92
2021-01-01 to 2021-09-3017,397,402USD273
2020-07-01 to 2020-09-304,819,213USD92
2020-01-01 to 2020-09-3017,289,065USD274

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2021-09-30518,481USD
At 2020-12-31760,530USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,826,011USD92
2021-01-01 to 2021-09-307,322,586USD273
2020-07-01 to 2020-09-302,482,792USD92
2020-01-01 to 2020-09-304,325,011USD274

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2021-07-01 to 2021-09-303,413,223USD92
2021-01-01 to 2021-09-3011,411,113USD273
2020-07-01 to 2020-09-303,121,023USD92
2020-01-01 to 2020-09-3011,997,185USD274

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2021-07-01 to 2021-09-30280,576USD92
2021-01-01 to 2021-09-30799,803USD273
2020-07-01 to 2020-09-3036,828USD92
2020-01-01 to 2020-09-30307,796USD274

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2021-09-309,826,599shares
At 2020-12-319,707,655shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2021-09-308,135,184USD
At 2020-12-3117,139,694USD
At 2020-09-30669,075USD
At 2019-12-312,145,812USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2021-09-3080,348,891USD
At 2020-12-3179,170,225USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2021-09-30502,697USD
At 2020-12-31579,535USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2021-09-30559,338USD
At 2020-12-31639,568USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2021-09-3026,982,098USD
At 2020-12-3132,160,919USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2021-09-30437,749USD
At 2020-12-31600,920USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2021-09-3011,594,114USD
At 2020-12-3114,683,786USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2021-09-302,748,238USD
At 2020-12-312,847,284USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2021-07-01 to 2021-09-30-1,694,553USD92
2021-01-01 to 2021-09-30-791,689USD273
2020-07-01 to 2020-09-30-3,306,506USD92
2020-01-01 to 2020-09-30-15,197,848USD274

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-800,734USD273
2020-01-01 to 2020-09-30-15,147,953USD274

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2021-07-01 to 2021-09-301,728,829USD92
2021-01-01 to 2021-09-305,186,486USD273
2020-07-01 to 2020-09-301,661,362USD92
2020-01-01 to 2020-09-304,984,084USD274

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

PeriodValueUnitDays
2020-01-01 to 2020-09-30-196,818USD274

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2021-01-01 to 2021-09-30393,577USD273
2020-01-01 to 2020-09-30953,171USD274

Operating lease payments

Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.

PeriodValueUnitDays
2021-07-01 to 2021-09-3045,942USD92
2021-01-01 to 2021-09-30137,826USD273
2020-07-01 to 2020-09-3045,660USD92
2020-01-01 to 2020-09-30136,979USD274

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-3,125,595USD273
2020-01-01 to 2020-09-301,548,687USD274

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-361,282USD273
2020-01-01 to 2020-09-30-565,486USD274

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2021-01-01 to 2021-09-30-297,212USD273
2020-01-01 to 2020-09-304,526,000USD274

Inspect the source

Entity
Petros Pharmaceuticals, Inc. / CIK 0001815903
Captured
2026-09-19T11:21:34.055Z
SEC response SHA-256
ce09757d7cf519fba34350164d20de41c934904fb0775c7180c184a51b39c633

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001815903.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))